Evolent Health Inc
NYSE:EVH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evolent Health Inc
NYSE:EVH
|
US |
|
G
|
Goldstorm Metals Corp
XTSX:GSTM
|
CA |
|
Food & Life Companies Ltd
TSE:3563
|
JP |
|
W
|
Westinghouse Air Brake Technologies Corp
XBER:WB2
|
US |
Balance Sheet
Balance Sheet Decomposition
Evolent Health Inc
Evolent Health Inc
Balance Sheet
Evolent Health Inc
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
5
|
68
|
0
|
146
|
135
|
238
|
228
|
101
|
319
|
266
|
188
|
193
|
104
|
152
|
|
| Cash |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
68
|
0
|
146
|
135
|
238
|
228
|
101
|
319
|
266
|
188
|
193
|
104
|
152
|
|
| Short-Term Investments |
0
|
0
|
0
|
9
|
44
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
11
|
0
|
20
|
41
|
69
|
82
|
77
|
124
|
131
|
255
|
447
|
415
|
310
|
|
| Accounts Receivables |
2
|
11
|
0
|
20
|
41
|
49
|
82
|
77
|
124
|
131
|
255
|
447
|
415
|
310
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
0
|
9
|
45
|
71
|
177
|
49
|
105
|
127
|
35
|
44
|
88
|
45
|
|
| Total Current Assets |
8
|
80
|
0
|
185
|
265
|
378
|
488
|
229
|
548
|
524
|
478
|
684
|
607
|
506
|
|
| PP&E Net |
4
|
14
|
0
|
13
|
31
|
51
|
74
|
157
|
144
|
132
|
137
|
90
|
79
|
85
|
|
| PP&E Gross |
4
|
14
|
0
|
13
|
31
|
51
|
74
|
157
|
144
|
132
|
137
|
90
|
79
|
85
|
|
| Accumulated Depreciation |
0
|
1
|
0
|
1
|
5
|
15
|
32
|
55
|
89
|
119
|
151
|
159
|
180
|
206
|
|
| Intangible Assets |
2
|
2
|
0
|
163
|
259
|
241
|
335
|
309
|
265
|
280
|
443
|
752
|
680
|
585
|
|
| Goodwill |
0
|
0
|
0
|
609
|
627
|
628
|
768
|
572
|
349
|
426
|
723
|
1 117
|
1 137
|
694
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
2
|
2
|
37
|
45
|
2
|
2
|
16
|
179
|
7
|
6
|
5
|
5
|
9
|
9
|
|
| Other Long-Term Assets |
0
|
4
|
0
|
2
|
16
|
13
|
40
|
51
|
60
|
52
|
32
|
33
|
32
|
19
|
|
| Other Assets |
0
|
0
|
0
|
609
|
627
|
628
|
768
|
572
|
349
|
426
|
723
|
1 117
|
1 137
|
694
|
|
| Total Assets |
16
N/A
|
102
+526%
|
37
-64%
|
1 016
+2 630%
|
1 200
+18%
|
1 313
+9%
|
1 722
+31%
|
1 498
-13%
|
1 372
-8%
|
1 420
+3%
|
1 817
+28%
|
2 680
+47%
|
2 544
-5%
|
1 899
-25%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
2
|
2
|
0
|
17
|
44
|
43
|
147
|
38
|
32
|
96
|
57
|
48
|
96
|
60
|
|
| Accrued Liabilities |
4
|
10
|
0
|
28
|
68
|
65
|
74
|
74
|
128
|
166
|
171
|
216
|
127
|
132
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
171
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
5
|
17
|
0
|
15
|
21
|
25
|
48
|
81
|
217
|
183
|
206
|
410
|
321
|
193
|
|
| Total Current Liabilities |
11
|
29
|
0
|
60
|
132
|
133
|
269
|
193
|
403
|
446
|
433
|
674
|
716
|
385
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
120
|
121
|
221
|
294
|
263
|
216
|
413
|
597
|
491
|
971
|
|
| Deferred Income Tax |
0
|
0
|
0
|
21
|
21
|
2
|
25
|
2
|
1
|
1
|
5
|
13
|
11
|
8
|
|
| Minority Interest |
0
|
0
|
0
|
285
|
210
|
35
|
46
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
3
|
0
|
0
|
15
|
10
|
17
|
81
|
85
|
63
|
107
|
150
|
136
|
121
|
|
| Total Liabilities |
11
N/A
|
33
+195%
|
0
N/A
|
366
N/A
|
497
+36%
|
302
-39%
|
579
+92%
|
576
0%
|
752
+31%
|
726
-3%
|
958
+32%
|
1 434
+50%
|
1 353
-6%
|
1 484
+10%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
69
|
39
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
180
|
191
|
1
|
|
| Retained Earnings |
21
|
0
|
26
|
307
|
147
|
86
|
50
|
252
|
589
|
627
|
606
|
719
|
781
|
1 315
|
|
| Additional Paid In Capital |
26
|
0
|
24
|
342
|
555
|
924
|
1 093
|
1 174
|
1 229
|
1 341
|
1 487
|
1 808
|
1 804
|
1 793
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
21
|
21
|
21
|
21
|
61
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Total Equity |
5
N/A
|
69
+1 233%
|
37
-46%
|
649
+1 645%
|
703
+8%
|
1 011
+44%
|
1 144
+13%
|
922
-19%
|
620
-33%
|
694
+12%
|
859
+24%
|
1 246
+45%
|
1 191
-4%
|
415
-65%
|
|
| Total Liabilities & Equity |
16
N/A
|
102
+526%
|
37
-64%
|
1 016
+2 630%
|
1 200
+18%
|
1 313
+9%
|
1 722
+31%
|
1 498
-13%
|
1 372
-8%
|
1 420
+3%
|
1 817
+28%
|
2 680
+47%
|
2 544
-5%
|
1 899
-25%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
56
|
56
|
56
|
59
|
68
|
77
|
82
|
85
|
84
|
89
|
100
|
114
|
115
|
112
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|